Product
Chiglitazar
7 clinical trials
7 indications
Indication
NASHIndication
Renal ImpairmentIndication
Type 2 Diabetes MellitusIndication
Liver ImpairmentIndication
DiabetesIndication
Type 2 DiabetesClinical trial
A Multi-Center, Randomised, Double-blind, Placebo Controlled Phase II Clinical Study of Chiglitazar in Patients With Nonalcoholic Steatohepatitis Accompanied by Elevated Triglycerides and Insulin ResistanceStatus: Recruiting, Estimated PCD: 2024-02-01
Clinical trial
A Phase I Study to Evaluate the Drug-Drug Interaction of Chiglitazar With Empagliflozin，Atorvastatin and Valsartan in Healthy Subjects.Status: Completed, Estimated PCD: 2023-03-21
Clinical trial
Study to Evaluate the Pharmacokinetics of Chiglitazar in Subjects With Renal Impairment and Normal Renal FunctionStatus: Recruiting, Estimated PCD: 2023-12-30
Clinical trial
Study to Evaluate the Pharmacokinetics of Chiglitazar in Subjects With Hepatic Impairment and Normal Hepatic FunctionStatus: Recruiting, Estimated PCD: 2023-10-30
Clinical trial
Chiglitazar Versus Metformin for Insulin Resistance in Non-obese Patients With Polycystic Ovary SyndromeStatus: , Estimated PCD: 2026-04-01
Clinical trial
A Prospective, Open, Self-controlled Study of the Effects of Chiglitazar Sodium on Glucose and Lipid Metabolism in Patients With Type 2 Diabetes Mellitus (T2DM)Status: Not yet recruiting, Estimated PCD: 2025-06-30
Clinical trial
Study on the Efficacy and Safety of Chiglitazar Sodium in the Treatment of Polycystic Ovary Syndrome With Type 2 DiabetesStatus: , Estimated PCD: 2023-09-30